CD19-CD34 CAR transduced T cells / Loyola University - LARVOL DELTA

CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies (clinicaltrials.gov) - P1 | N=24 | Active, not recruiting | Sponsor: Loyola University | Recruiting ➔ Active, not recruiting | Trial primary completion date: Dec 2021 ➔ Aug 2022

Enrollment closed • Trial primary completion date • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • Hematological Malignancies • Leukemia • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • CD19 • CD34